Señales en vivo de ONVO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 may 2024 @ 16:00):

Stats
Volumen de hoy	152 966
Volumen promedio	1.06M
Capitalización de mercado	14.03M
EPS	$0 ( 2024-02-08 )
Próxima fecha de ganancias	( $-0.420 ) 2024-07-11
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.500
ATR14	$0.00500 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-17	Stern Adam K	Buy	19 607	Common Stock
2023-11-17	Milhous Alison Tjosvold	Buy	19 607	Common Stock
2023-11-17	Cohen Douglas Jay	Buy	19 607	Common Stock
2023-11-17	Murphy Keith	Buy	19 607	Common Stock
2023-11-17	Gobel David	Buy	19 607	Common Stock

INSIDER POWER
80.75
Last 90 transactions
Buy: 3 116 580 \| Sell: 414 691

Volumen Correlación

Largo: 0.02 (neutral)

Corto: -0.73 (moderate negative)

Signal:(46.812) Neutral

Organovo Holdings Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Organovo Holdings Inc Correlación - Moneda/Commodity

-0.10
( neutral )

0.23
( neutral )

0.00
( neutral )

0.45
( neutral )

0.00
( neutral )

-0.48
( neutral )

Organovo Holdings Inc Finanzas

Annual	2022
Ingresos:	$370 000
Beneficio Bruto:	$77 000.00 (20.81 %)
EPS:	$-1.980

FY	2022
Ingresos:	$370 000
Beneficio Bruto:	$77 000.00 (20.81 %)
EPS:	$-1.980

FY	2022
Ingresos:	$1.50M
Beneficio Bruto:	$1.50M (100.00 %)
EPS:	$-1.320

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.44

Financial Reports:

No articles found.

Organovo Holdings Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Organovo Holdings Inc

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.